|
|
|
Volumn 323, Issue 7314, 2001, Pages 695-
|
|
Removal of thioridazine from primary care formulary will result in prescribing vacuum [8]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BENZODIAZEPINE DERIVATIVE;
NEUROLEPTIC AGENT;
THIORIDAZINE;
CLINICAL PRACTICE;
DRUG CHOICE;
DRUG INDICATION;
ELECTROCARDIOGRAM;
HEART ARRHYTHMIA;
HUMAN;
LETTER;
PHYSICIAN ATTITUDE;
PRESCRIPTION;
PRIMARY MEDICAL CARE;
PRIORITY JOURNAL;
QT INTERVAL;
SCHIZOPHRENIA;
SUDDEN DEATH;
VACUUM;
ANTIPSYCHOTIC AGENTS;
DOPAMINE ANTAGONISTS;
FORMULARIES;
GREAT BRITAIN;
HUMANS;
PRIMARY HEALTH CARE;
THIORIDAZINE;
|
|
EID: 0035934619
PISSN: 09598146
EISSN: None
Source Type: Journal
DOI: None Document Type: Letter |
|
Times cited : (4)
|
|
References (5)
|
